Odronextamab (REGN1979), a Human CD20 x CD3 Bispecific Antibody, Induces Durable, Complete Responses in Patients with Highly Refractory B-Cell Non-Hodgkin Lymphoma, Including Patients Refractory to CAR T TherapyRajat Bannerji, Max S. Topp, Ranjana H. Advani et al.|Blood|2020Cited by 108
Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)Rajat Bannerji, Max S. Topp, John N. Allan et al.|Blood|2019Cited by 57